19-43018993-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002785.3(PSG11):c.486G>T(p.Met162Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,611,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002785.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSG11 | NM_002785.3 | c.486G>T | p.Met162Ile | missense_variant | 3/6 | ENST00000320078.12 | NP_002776.3 | |
PSG11 | NM_001113410.2 | c.120G>T | p.Met40Ile | missense_variant | 2/5 | NP_001106881.1 | ||
PSG11 | NM_203287.2 | c.120G>T | p.Met40Ile | missense_variant | 2/5 | NP_976032.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSG11 | ENST00000320078.12 | c.486G>T | p.Met162Ile | missense_variant | 3/6 | 2 | NM_002785.3 | ENSP00000319140 | P2 | |
PSG11-AS1 | ENST00000635495.1 | n.182+41349C>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251208Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135746
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460696Hom.: 0 Cov.: 34 AF XY: 0.0000151 AC XY: 11AN XY: 726630
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151258Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73856
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.486G>T (p.M162I) alteration is located in exon 3 (coding exon 3) of the PSG11 gene. This alteration results from a G to T substitution at nucleotide position 486, causing the methionine (M) at amino acid position 162 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at